Final-Program-ATS-2023-AP.vp

32

SATURDAY • MAY 20

2:40 Workshop 1 - Translational and Multidisciplinary Lung Microengineering K. Hajipouran Benam, PhD, Pittsburgh, PA 3:10 Workshop 2 - High-Throughput Omics Guides Therapeutic Targeting M. Sauler, MD, New Haven, CT 3:40 Closing Discussion I.M. Adcock, PhD, London, United Kingdom This session and the International Conference are supported by an independent medical educational grant from AstraZeneca LP. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

Chairing: Y. Tesfaigzi, PhD, Boston, MA

E.R. Neptune, MD, ATSF, Baltimore, MD I.M. Adcock, PhD, London, United Kingdom M.P. Goldklang, MD, New York, NY 8:00 The Future of COPD Research - How We Can Model Susceptibility, Exposures and the Resultant Endotypes? A.O. Yildirim, PhD, Munich, Germany COPD Setting the Scene 8:16 Air Pollution - The Forgotten Etiology of COPD E. Coffman, BS, MPH, Durham, NC 8:36 Genetic Susceptibility B.D. Hobbs, MD, MSc, Boston, MA 8:56 The Pathological Mechanisms of COPD P.J. Barnes, MD, DSc, ATSF, London, United Kingdom 9:16 A Multi Edged Sword - Heterogeneity in COPD J.A. Wedzicha, MD, ATSF, London, United Kingdom 9:36 Break Immune Targets in COPD 10:07 Adaptive Immune Cells in COPD F. Polverino, MD, PhD, Houston, TX 10:27 Specialized Pro Resolving Molecules: A New Approach to Resolution of Inflammation P.J. Sime, MD, ATSF, Richmond, VA 10:47 Novel Immune-Therapeutic Targets in COPD T.M. Conlon, PhD, Munich, Germany Metabolic Targets in COPD 11:08 Mitochondrial Dysfunction in COPD C.R. Kliment, MD, PhD, Pittsburgh, PA 11:28 Disease Pathogenesis Stems From Altered Immunometabolic Processes S.M. Cloonan, PhD, New York, NY 11:48 Lunch and Group Discussions Lets Regenerate the Lung 12:49 Remodeling and Tissue Repair C. Kim, PhD, Boston, MA 1:09 Silencing Senescence M. Lehmann, PhD, Munich, Germany 1:29 Novel Transcriptomics-Guided Approaches for Druggable Targets R. Gosens, PhD, Groningen, Netherlands Tricks and Tools 1:50 Ultra-Resolution Biomedical Imaging T. Hackett, PhD, ATSF, Vancouver, Canada 2:10 Break

CLINICAL POSTGRADUATE COURSE CME Credits Available: 6.75

PG13 HUFFING AND PUFFING: BEST

PRACTICE AND STATE OF THE ART IN CPET AND PFT R Pre-registration and additional fees required. Attendance is limited. Member: $440 In-Training Member: $255 LMIC Member: $310 LMIC In-Training Member: $180 Non-Member: $540 In-Training Non-Member: $380 Assemblies on Respiratory Structure and Function; Clinical Problems; Pulmonary Rehabilitation 8:00 AM - 4:00 PM Marriott Marquis Washington Liberty Ballroom, Salons I-K (Level M4) Target Audience Current and future directors of PFT and CPET labs, attending physicians, respiratory therapists, clinical physiologists, trainees, fellows, and other interested health care providers. Objectives At the conclusion of this session, the participant will be able to: • integrate/incorporate the principles and practice of pulmonary function diagnostic tests • improve and develop greater confidence interpreting pulmonary function test results in clinical practice • apply and improve the performance and interpretation of cardiopulmonary exercise testing This course will focus on clinical physiology, combining guidelines from the new technical standards published in the past three years and interpretive strategies document published in the last year with interactive experience in small group settings focusing on the performance, interpretation, and reporting of pulmonary function testing (PFT) and cardiopulmonary exercise testing

ATS 2023 • Washington, DC